1. Home
  2. MTN vs QTTB Comparison

MTN vs QTTB Comparison

Compare MTN & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vail Resorts Inc.

MTN

Vail Resorts Inc.

HOLD

Current Price

$161.76

Market Cap

5.2B

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$2.94

Market Cap

25.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTN
QTTB
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
25.1M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
MTN
QTTB
Price
$161.76
$2.94
Analyst Decision
Hold
Hold
Analyst Count
10
4
Target Price
$176.50
$7.33
AVG Volume (30 Days)
903.5K
9.0M
Earning Date
12-10-2025
11-13-2025
Dividend Yield
5.49%
N/A
EPS Growth
17.26
N/A
EPS
7.24
N/A
Revenue
$2,975,101,000.00
N/A
Revenue This Year
$2.69
N/A
Revenue Next Year
$3.45
N/A
P/E Ratio
$22.34
N/A
Revenue Growth
3.06
N/A
52 Week Low
$129.85
$1.35
52 Week High
$196.64
$8.48

Technical Indicators

Market Signals
Indicator
MTN
QTTB
Relative Strength Index (RSI) 69.96 51.82
Support Level $140.00 $3.06
Resistance Level $146.91 $3.96
Average True Range (ATR) 4.35 0.51
MACD 2.37 0.03
Stochastic Oscillator 98.39 22.32

Price Performance

Historical Comparison
MTN
QTTB

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: